GPT and metabolic dysfunction-associated steatotic liver disease: This prospective observational study aimed to evaluate the effect of statin therapy on liver enzymes and the progression of liver fibrosis in patients with coexisting CVD and NAFLD. The results demonstrate that statin therapy produced a marked improvement in liver enzyme levels (ALT and AST) and was associated with a reduced rate of fibrosis progression in this high-risk patient population.